α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients

被引:49
作者
Hücking, K
Kostic, Z
Pox, C
Ritzel, R
Holst, JJ
Schmiegel, W
Nauck, MA
机构
[1] Diabet Zentrum Bad Lauterberg, D-37431 Bad Lauterberg im Harz, Germany
[2] Knappschaftskrankenhaus Bochum Langendreer, Med Univ Klin, Bochum, Germany
[3] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark
关键词
alpha-glucosidase inhibition; acarbose; GIP; GLP-1 (7-36 amide); hyperglycaemia; incretin hormones; insulin secretion; type; 2-diabetes;
D O I
10.1111/j.1464-5491.2005.01451.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Acarbose is able to enhance GLP-1 release and delay gastric emptying in normal subjects. The effect of alpha-glucosidase inhibition on GLP-1 has been less evident in Type 2 diabetic patients. The aim of this study was to investigate the possible influence of acarbose on GLP-1 release and gastric emptying in Type 2 diabetic patients after a mixed test meal. Patients and methods Ten Type 2 diabetic patients were tested with 100 mg acarbose or placebo served with a mixed meal that was labelled with 100 mg C-13-octanoic acid. Plasma concentrations of glucose, insulin, C-peptide, glucagon, GLP-1 and GIP were determined over 6 h. Gastric emptying was measured by determining breath (CO2)-C-13 using infrared absorptiometry. Statistics repeated-measures ANOVA. Results Gastric emptying rates (t(1/2): 162 +/- 45 vs. 163 +/- 62 min, P = 0.65) and plasma concentrations (increasing from approximate to 12 to approximate to 25 pmol/l, P = 0.37) and integrated responses of GLP-1 (P = 0.37) were not changed significantly by acarbose treatment. Postprandial plasma glucose concentrations (P < 0.0001) and their integrated responses were lowered by acarbose (by 64%; P = 0.016). The plasma concentrations of insulin and C-peptide were reduced (P = 0.007 and 0.057, respectively) by acarbose, while glucagon was not changed (P = 0.96). GIP plasma concentrations (increasing with placebo from approximate to 10 to approximate to 85 pmol/l and with acarbose to approximate to 55 pmol/l (P < 0.0001) and their integrated responses were significantly lowered (by 43%) by acarbose (P = 0.021). After 2 weeks of acarbose treatment (50 mg t.i.d. for the first and 100 mg t.i.d. for the second week, n = 6), similar results were found. conclusions In hyperglycaemic Type 2 diabetic patients, ingestion of acarbose with a mixed test meal failed to enhance GLP-1 release and did not influence gastric emptying.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 40 条
[21]   ADDITIVE INSULINOTROPIC EFFECTS OF EXOGENOUS SYNTHETIC HUMAN GASTRIC-INHIBITORY POLYPEPTIDE AND GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE INFUSED AT NEAR-PHYSIOLOGICAL INSULINOTROPIC HORMONE AND GLUCOSE-CONCENTRATIONS [J].
NAUCK, MA ;
BARTELS, E ;
ORSKOV, C ;
EBERT, R ;
CREUTZFELDT, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04) :912-917
[22]   Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes [J].
Nauck, MA ;
Holst, JJ ;
Willms, B ;
Schmiegel, W .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (04) :187-195
[23]   INTESTINAL BRUSH-BORDER MEMBRANE IN DIABETES - STUDIES OF SUCRASE-ISOMALTASE METABOLISM IN RATS WITH STREPTOZOTOCIN DIABETES [J].
OLSEN, WA ;
KORSMO, H .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) :181-188
[24]  
ORSKOV C, 1987, SCAND J CLIN LAB INV, V47, P165
[25]   TISSUE AND PLASMA-CONCENTRATIONS OF AMIDATED AND GLYCINE-EXTENDED GLUCAGON-LIKE PEPTIDE-I IN HUMANS [J].
ORSKOV, C ;
RABENHOJ, L ;
WETTERGREN, A ;
KOFOD, H ;
HOLST, JJ .
DIABETES, 1994, 43 (04) :535-539
[26]   PLASMA INSULIN RESPONSES TO ORAL AND INTRAVENOUS GLUCOSE - STUDIES IN NORMAL AND DIABETIC SUBJECTS [J].
PERLEY, MJ ;
KIPNIS, DM .
JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (12) :1954-&
[27]   GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINAL SUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) [J].
QUALMANN, C ;
NAUCK, MA ;
HOLST, JJ ;
ORSKOV, C ;
CREUTZFELDT, W .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (09) :892-896
[28]  
Ranganath L, 1998, DIABETIC MED, V15, P120, DOI 10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO
[29]  
2-I
[30]   Guide for judicious use of the paracetamol absorption technique in a study of gastric emptying rate of liquids [J].
Sanaka, M ;
Kuyama, Y ;
Yamanaka, M .
JOURNAL OF GASTROENTEROLOGY, 1998, 33 (06) :785-791